Polymyxin B2 is a polymyxin-class antibiotic utilized for its efficacy against serious Gram-negative bacterial infections, including those caused by multidrug-resistant pathogens such as Pseudomonas aeruginosa… Read more
Polymyxin B2 is a polymyxin-class antibiotic utilized for its efficacy against serious Gram-negative bacterial infections, including those caused by multidrug-resistant pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii. As a cationic peptide, it functions by disrupting bacterial cell membranes to inhibit pathogen growth. This category contains essential reference standards, related impurities, metabolites, and stable isotope-labelled compounds required for rigorous pharmaceutical analysis. Laboratories rely on these high-quality materials for impurity profiling, method validation, and ongoing quality control during the development and testing of antibiotic formulations. By utilizing these precise analytical tools, researchers can ensure compliance with regulatory standards and accurately quantify drug content and degradation products, supporting the safety and efficacy assessments necessary in complex antibacterial drug development.